

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.41443504 |
| 2 | synaptic vesicle maturation (GO:0016188) | 4.88162159 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.79381205 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.73014833 |
| 5 | locomotory exploration behavior (GO:0035641) | 4.72116936 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 4.49257598 |
| 7 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.31013170 |
| 8 | definitive hemopoiesis (GO:0060216) | 4.17258605 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.16517727 |
| 10 | vocalization behavior (GO:0071625) | 4.12521769 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.04044954 |
| 12 | glutamate secretion (GO:0014047) | 4.02583204 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.00713502 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.98541400 |
| 15 | protein localization to synapse (GO:0035418) | 3.97223499 |
| 16 | glutamate receptor signaling pathway (GO:0007215) | 3.96119781 |
| 17 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.89912616 |
| 18 | cellular potassium ion homeostasis (GO:0030007) | 3.86979910 |
| 19 | Golgi to endosome transport (GO:0006895) | 3.82073955 |
| 20 | regulation of ARF protein signal transduction (GO:0032012) | 3.78481636 |
| 21 | response to histamine (GO:0034776) | 3.75679647 |
| 22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.71762238 |
| 23 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.68748394 |
| 24 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.68601221 |
| 25 | synaptic vesicle endocytosis (GO:0048488) | 3.68522872 |
| 26 | regulation of synaptic vesicle transport (GO:1902803) | 3.67523846 |
| 27 | exploration behavior (GO:0035640) | 3.65265599 |
| 28 | iron ion import (GO:0097286) | 3.57475678 |
| 29 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.53663504 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 3.52640225 |
| 31 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.51686139 |
| 32 | sodium ion export (GO:0071436) | 3.49614009 |
| 33 | layer formation in cerebral cortex (GO:0021819) | 3.44669665 |
| 34 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.43562328 |
| 35 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.41100848 |
| 36 | neurotransmitter secretion (GO:0007269) | 3.37522581 |
| 37 | neuron-neuron synaptic transmission (GO:0007270) | 3.36887884 |
| 38 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.36216618 |
| 39 | negative regulation of cell killing (GO:0031342) | 3.36216618 |
| 40 | long-term memory (GO:0007616) | 3.34769000 |
| 41 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.33364981 |
| 42 | neuronal action potential propagation (GO:0019227) | 3.31071285 |
| 43 | neuron cell-cell adhesion (GO:0007158) | 3.30243805 |
| 44 | regulation of postsynaptic membrane potential (GO:0060078) | 3.30089493 |
| 45 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.28655297 |
| 46 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.24147793 |
| 47 | regulation of synapse structural plasticity (GO:0051823) | 3.21908702 |
| 48 | proline transport (GO:0015824) | 3.19578495 |
| 49 | phospholipid translocation (GO:0045332) | 3.18776090 |
| 50 | lipid translocation (GO:0034204) | 3.18776090 |
| 51 | activation of protein kinase A activity (GO:0034199) | 3.18322773 |
| 52 | detection of calcium ion (GO:0005513) | 3.18047852 |
| 53 | cellular response to ethanol (GO:0071361) | 3.18002500 |
| 54 | early endosome to late endosome transport (GO:0045022) | 3.17864723 |
| 55 | regulation of Rac protein signal transduction (GO:0035020) | 3.14178363 |
| 56 | vesicle transport along microtubule (GO:0047496) | 3.14035948 |
| 57 | positive regulation of Rap GTPase activity (GO:0032854) | 3.09583886 |
| 58 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.09059866 |
| 59 | positive regulation of membrane potential (GO:0045838) | 3.08856042 |
| 60 | long-term synaptic potentiation (GO:0060291) | 3.07606190 |
| 61 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 3.05272542 |
| 62 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.04899032 |
| 63 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.04823564 |
| 64 | regulation of synaptic plasticity (GO:0048167) | 3.02386114 |
| 65 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.00234914 |
| 66 | positive regulation of synapse maturation (GO:0090129) | 2.97014332 |
| 67 | import into cell (GO:0098657) | 2.93954081 |
| 68 | innervation (GO:0060384) | 2.92918378 |
| 69 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.92894590 |
| 70 | positive regulation of vesicle fusion (GO:0031340) | 2.91307500 |
| 71 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.90624205 |
| 72 | regulation of vesicle fusion (GO:0031338) | 2.89908227 |
| 73 | protein targeting to Golgi (GO:0000042) | 2.88906210 |
| 74 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.88782003 |
| 75 | regulation of beta-amyloid formation (GO:1902003) | 2.88583722 |
| 76 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.86942556 |
| 77 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.86334536 |
| 78 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.85923787 |
| 79 | negative regulation of neurotransmitter transport (GO:0051589) | 2.85825072 |
| 80 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.85679988 |
| 81 | dendritic spine morphogenesis (GO:0060997) | 2.85609698 |
| 82 | interkinetic nuclear migration (GO:0022027) | 2.84390662 |
| 83 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.83903491 |
| 84 | behavioral fear response (GO:0001662) | 2.83822407 |
| 85 | behavioral defense response (GO:0002209) | 2.83822407 |
| 86 | establishment of protein localization to Golgi (GO:0072600) | 2.82829088 |
| 87 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.82445132 |
| 88 | regulation of Rap GTPase activity (GO:0032317) | 2.81803995 |
| 89 | regulation of neurotransmitter secretion (GO:0046928) | 2.80319509 |
| 90 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.80153054 |
| 91 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.79284666 |
| 92 | membrane depolarization during action potential (GO:0086010) | 2.79267608 |
| 93 | gamma-aminobutyric acid transport (GO:0015812) | 2.78186537 |
| 94 | phospholipid dephosphorylation (GO:0046839) | 2.77562382 |
| 95 | neurotransmitter transport (GO:0006836) | 2.76426381 |
| 96 | peptidyl-threonine phosphorylation (GO:0018107) | 2.76049382 |
| 97 | chemosensory behavior (GO:0007635) | 2.75894583 |
| 98 | membrane depolarization (GO:0051899) | 2.75540329 |
| 99 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.74632729 |
| 100 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.73492788 |
| 101 | L-amino acid import (GO:0043092) | 2.72345350 |
| 102 | neuromuscular process controlling balance (GO:0050885) | 2.70348974 |
| 103 | dendrite morphogenesis (GO:0048813) | 2.70192963 |
| 104 | nerve growth factor signaling pathway (GO:0038180) | 2.69728250 |
| 105 | peptidyl-threonine modification (GO:0018210) | 2.68792193 |
| 106 | positive regulation of neurotransmitter transport (GO:0051590) | 2.67992767 |
| 107 | neuron recognition (GO:0008038) | 2.66555238 |
| 108 | fear response (GO:0042596) | 2.65998408 |
| 109 | positive regulation of protein autophosphorylation (GO:0031954) | 2.65111485 |
| 110 | suckling behavior (GO:0001967) | 2.63098014 |
| 111 | positive regulation of fibroblast migration (GO:0010763) | 2.62402127 |
| 112 | positive regulation of glycolytic process (GO:0045821) | 2.62347388 |
| 113 | clathrin coat assembly (GO:0048268) | 2.60348744 |
| 114 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.59054358 |
| 115 | macroautophagy (GO:0016236) | 2.58917736 |
| 116 | mating behavior (GO:0007617) | 2.58879955 |
| 117 | regulation of dendritic spine development (GO:0060998) | 2.58126444 |
| 118 | long term synaptic depression (GO:0060292) | 2.57558240 |
| 119 | regulation of neurotransmitter transport (GO:0051588) | 2.57423358 |
| 120 | protein targeting to lysosome (GO:0006622) | 2.56886705 |
| 121 | establishment of protein localization to vacuole (GO:0072666) | 2.56886705 |
| 122 | protein targeting to vacuole (GO:0006623) | 2.56886705 |
| 123 | regulation of neurotransmitter levels (GO:0001505) | 2.54282451 |
| 124 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.53881608 |
| 125 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.52444735 |
| 126 | positive regulation of synaptic transmission (GO:0050806) | 2.51514046 |
| 127 | learning (GO:0007612) | 2.49876722 |
| 128 | transmission of nerve impulse (GO:0019226) | 2.49342256 |
| 129 | inositol phosphate catabolic process (GO:0071545) | 2.48660727 |
| 130 | axonal fasciculation (GO:0007413) | 2.48457300 |
| 131 | protein K11-linked deubiquitination (GO:0035871) | 2.48435658 |
| 132 | intraspecies interaction between organisms (GO:0051703) | 2.48248488 |
| 133 | social behavior (GO:0035176) | 2.48248488 |
| 134 | prepulse inhibition (GO:0060134) | 2.48141961 |
| 135 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.47930228 |
| 136 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.46218995 |
| 137 | insulin secretion (GO:0030073) | 2.44633877 |
| 138 | detection of molecule of bacterial origin (GO:0032490) | 2.36032950 |
| 139 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.35827907 |
| 140 | regulation of protein glycosylation (GO:0060049) | 2.35016133 |
| 141 | response to nerve growth factor (GO:1990089) | 2.32810510 |
| 142 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.32810510 |
| 143 | phosphorelay signal transduction system (GO:0000160) | 2.28819299 |
| 144 | polyol catabolic process (GO:0046174) | 2.28093358 |
| 145 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.23897870 |
| 146 | cellular response to epinephrine stimulus (GO:0071872) | 2.23561482 |
| 147 | negative regulation of dendrite development (GO:2000171) | 2.21042211 |
| 148 | vesicle docking involved in exocytosis (GO:0006904) | 2.19121772 |
| 149 | regulation of platelet aggregation (GO:0090330) | 2.15402454 |
| 150 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.15168827 |
| 151 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.14871320 |
| 152 | regulation of pigment cell differentiation (GO:0050932) | 2.13752699 |
| 153 | snRNA transcription (GO:0009301) | 2.13640896 |
| 154 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.13449336 |
| 155 | positive regulation of granulocyte differentiation (GO:0030854) | 2.13034105 |
| 156 | response to methylmercury (GO:0051597) | 2.12853571 |
| 157 | hypotonic response (GO:0006971) | 2.12517637 |
| 158 | cerebellar granule cell differentiation (GO:0021707) | 2.12196947 |
| 159 | negative regulation of adherens junction organization (GO:1903392) | 2.11922736 |
| 160 | negative regulation of focal adhesion assembly (GO:0051895) | 2.11922736 |
| 161 | negative regulation of cell junction assembly (GO:1901889) | 2.11922736 |
| 162 | vesicle docking (GO:0048278) | 2.11595948 |
| 163 | regulation of establishment of cell polarity (GO:2000114) | 2.11143535 |
| 164 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.10321442 |
| 165 | positive regulation of macroautophagy (GO:0016239) | 2.08268612 |
| 166 | cell differentiation in hindbrain (GO:0021533) | 2.07812111 |
| 167 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.07174223 |
| 168 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.05640811 |
| 169 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.05557347 |
| 170 | inositol phosphate dephosphorylation (GO:0046855) | 2.05557347 |
| 171 | positive regulation of muscle hypertrophy (GO:0014742) | 2.05332435 |
| 172 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.05332435 |
| 173 | phosphatidylinositol phosphorylation (GO:0046854) | 2.04071876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.60862210 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.60858623 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.26436960 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.50655866 |
| 5 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.39089717 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.30764756 |
| 7 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.25712050 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.24826210 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.19573816 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.17664758 |
| 11 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.09908569 |
| 12 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.06703731 |
| 13 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.04393458 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.02063592 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.00342902 |
| 16 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.97439863 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.94296843 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.93766236 |
| 19 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.91397571 |
| 20 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.91397571 |
| 21 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.87502266 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.82996638 |
| 23 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77925356 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.73455708 |
| 25 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.72290939 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.66570845 |
| 27 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.65563171 |
| 28 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.62454684 |
| 29 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.60187629 |
| 30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.59591930 |
| 31 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.58031546 |
| 32 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.57866680 |
| 33 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.57866680 |
| 34 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.57709324 |
| 35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.57312291 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.57311505 |
| 37 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57093414 |
| 38 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.56911644 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.55347805 |
| 40 | TP53_16413492_ChIP-PET_HCT116_Human | 1.54758650 |
| 41 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.53658653 |
| 42 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.52832160 |
| 43 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.52491396 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52275507 |
| 45 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.52242187 |
| 46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.51258188 |
| 47 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.48925367 |
| 48 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.48834626 |
| 49 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.48107034 |
| 50 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.46473990 |
| 51 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45886805 |
| 52 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.43160636 |
| 53 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.42500200 |
| 54 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.39266667 |
| 55 | P300_19829295_ChIP-Seq_ESCs_Human | 1.38941750 |
| 56 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.37832811 |
| 57 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36951288 |
| 58 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.36477526 |
| 59 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.36102634 |
| 60 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.35482418 |
| 61 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.35437475 |
| 62 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.34188937 |
| 63 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.33559822 |
| 64 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33404598 |
| 65 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.32810727 |
| 66 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.32686808 |
| 67 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.29968324 |
| 68 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.29287792 |
| 69 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28903042 |
| 70 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.28080074 |
| 71 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.27525219 |
| 72 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.27235076 |
| 73 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.27095278 |
| 74 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27072715 |
| 75 | AR_19668381_ChIP-Seq_PC3_Human | 1.26943372 |
| 76 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26871816 |
| 77 | TCF4_23295773_ChIP-Seq_U87_Human | 1.26262995 |
| 78 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.26075258 |
| 79 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.25570965 |
| 80 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.24455308 |
| 81 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.24200711 |
| 82 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.23393859 |
| 83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21521611 |
| 84 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.20847881 |
| 85 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.20475668 |
| 86 | RXR_22108803_ChIP-Seq_LS180_Human | 1.19922552 |
| 87 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.19428853 |
| 88 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.18420467 |
| 89 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17788371 |
| 90 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.17399179 |
| 91 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.17373825 |
| 92 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16776377 |
| 93 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16045071 |
| 94 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.15930421 |
| 95 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15561550 |
| 96 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.15438475 |
| 97 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.14794414 |
| 98 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.14163760 |
| 99 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12038965 |
| 100 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.11568927 |
| 101 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11065999 |
| 102 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.11055682 |
| 103 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10708305 |
| 104 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.10028947 |
| 105 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09755106 |
| 106 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.09706672 |
| 107 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09688959 |
| 108 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.09498823 |
| 109 | KDM2B_26808549_Chip-Seq_K562_Human | 1.08034751 |
| 110 | CJUN_26792858_Chip-Seq_BT549_Human | 1.07348987 |
| 111 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.07041074 |
| 112 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.06954636 |
| 113 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05834599 |
| 114 | FUS_26573619_Chip-Seq_HEK293_Human | 1.04946872 |
| 115 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.04020173 |
| 116 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.03808008 |
| 117 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.03660144 |
| 118 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.03496774 |
| 119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03210608 |
| 120 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.03120828 |
| 121 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.02764628 |
| 122 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.02282813 |
| 123 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01974948 |
| 124 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.01974948 |
| 125 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01720788 |
| 126 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.01302132 |
| 127 | TBL1_22424771_ChIP-Seq_293T_Human | 1.00785287 |
| 128 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.99114432 |
| 129 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98962254 |
| 130 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.98229137 |
| 131 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97982798 |
| 132 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97599146 |
| 133 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97062212 |
| 134 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.96991672 |
| 135 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96510204 |
| 136 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96012743 |
| 137 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95854436 |
| 138 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.95422128 |
| 139 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.95364419 |
| 140 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.94956958 |
| 141 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94664845 |
| 142 | KDM2B_26808549_Chip-Seq_REH_Human | 0.94620567 |
| 143 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91787982 |
| 144 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.91362273 |
| 145 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.89539134 |
| 146 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89502964 |
| 147 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88641396 |
| 148 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86894841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.54675538 |
| 2 | MP0000569_abnormal_digit_pigmentation | 4.36763839 |
| 3 | MP0003880_abnormal_central_pattern | 3.99266807 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 3.86743388 |
| 5 | MP0004270_analgesia | 3.29632726 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 3.14627181 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.08701574 |
| 8 | MP0009745_abnormal_behavioral_response | 3.02533973 |
| 9 | MP0002064_seizures | 2.89931913 |
| 10 | MP0009046_muscle_twitch | 2.63857074 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.63208850 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.56862779 |
| 13 | MP0002009_preneoplasia | 2.56505130 |
| 14 | MP0008438_abnormal_cutaneous_collagen | 2.53560310 |
| 15 | MP0004147_increased_porphyrin_level | 2.36159211 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.33866258 |
| 17 | MP0001486_abnormal_startle_reflex | 2.26071290 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.23000593 |
| 19 | MP0008057_abnormal_DNA_replication | 2.21843569 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.19705477 |
| 21 | MP0003787_abnormal_imprinting | 2.17972133 |
| 22 | MP0000013_abnormal_adipose_tissue | 2.16288453 |
| 23 | MP0005423_abnormal_somatic_nervous | 2.14774998 |
| 24 | MP0002734_abnormal_mechanical_nocicepti | 2.11820089 |
| 25 | MP0002272_abnormal_nervous_system | 2.09218834 |
| 26 | MP0004134_abnormal_chest_morphology | 2.03740216 |
| 27 | MP0005360_urolithiasis | 2.01799153 |
| 28 | MP0002909_abnormal_adrenal_gland | 1.96153479 |
| 29 | MP0003183_abnormal_peptide_metabolism | 1.95740368 |
| 30 | MP0002736_abnormal_nociception_after | 1.94548193 |
| 31 | MP0006054_spinal_hemorrhage | 1.93704123 |
| 32 | MP0002735_abnormal_chemical_nociception | 1.87586776 |
| 33 | MP0005275_abnormal_skin_tensile | 1.86862350 |
| 34 | MP0004510_myositis | 1.86681936 |
| 35 | MP0001440_abnormal_grooming_behavior | 1.83529164 |
| 36 | MP0003303_peritoneal_inflammation | 1.81062460 |
| 37 | MP0005551_abnormal_eye_electrophysiolog | 1.80262404 |
| 38 | MP0002067_abnormal_sensory_capabilities | 1.78907296 |
| 39 | MP0008569_lethality_at_weaning | 1.76408456 |
| 40 | MP0003656_abnormal_erythrocyte_physiolo | 1.74195439 |
| 41 | MP0005174_abnormal_tail_pigmentation | 1.68934460 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.67925484 |
| 43 | MP0001970_abnormal_pain_threshold | 1.67910812 |
| 44 | MP0002733_abnormal_thermal_nociception | 1.63013977 |
| 45 | MP0003329_amyloid_beta_deposits | 1.62812313 |
| 46 | MP0004858_abnormal_nervous_system | 1.61794779 |
| 47 | MP0005646_abnormal_pituitary_gland | 1.61724009 |
| 48 | MP0004811_abnormal_neuron_physiology | 1.60675066 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.60286099 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.53518693 |
| 51 | MP0002166_altered_tumor_susceptibility | 1.52913610 |
| 52 | MP0002822_catalepsy | 1.51614944 |
| 53 | MP0005386_behavior/neurological_phenoty | 1.49914371 |
| 54 | MP0004924_abnormal_behavior | 1.49914371 |
| 55 | MP0008961_abnormal_basal_metabolism | 1.49633357 |
| 56 | MP0003879_abnormal_hair_cell | 1.48849803 |
| 57 | MP0010678_abnormal_skin_adnexa | 1.45816430 |
| 58 | MP0010386_abnormal_urinary_bladder | 1.45674659 |
| 59 | MP0000015_abnormal_ear_pigmentation | 1.43034431 |
| 60 | MP0003633_abnormal_nervous_system | 1.40564580 |
| 61 | MP0002184_abnormal_innervation | 1.40003722 |
| 62 | MP0002557_abnormal_social/conspecific_i | 1.39078186 |
| 63 | MP0000604_amyloidosis | 1.38786543 |
| 64 | MP0001984_abnormal_olfaction | 1.27409514 |
| 65 | MP0003724_increased_susceptibility_to | 1.27280751 |
| 66 | MP0003300_gastrointestinal_ulcer | 1.26755364 |
| 67 | MP0005409_darkened_coat_color | 1.26109003 |
| 68 | MP0001188_hyperpigmentation | 1.24674381 |
| 69 | MP0005397_hematopoietic_system_phenotyp | 1.22202040 |
| 70 | MP0001545_abnormal_hematopoietic_system | 1.22202040 |
| 71 | MP0002882_abnormal_neuron_morphology | 1.21012826 |
| 72 | MP0002229_neurodegeneration | 1.20869275 |
| 73 | MP0000778_abnormal_nervous_system | 1.14822638 |
| 74 | MP0002066_abnormal_motor_capabilities/c | 1.11444543 |
| 75 | MP0002090_abnormal_vision | 1.11093191 |
| 76 | MP0003075_altered_response_to | 1.10489351 |
| 77 | MP0005058_abnormal_lysosome_morphology | 1.09893561 |
| 78 | MP0003091_abnormal_cell_migration | 1.08736284 |
| 79 | MP0000955_abnormal_spinal_cord | 1.07767464 |
| 80 | MP0003631_nervous_system_phenotype | 1.06890757 |
| 81 | MP0001958_emphysema | 1.05727172 |
| 82 | MP0003950_abnormal_plasma_membrane | 1.04535239 |
| 83 | MP0005310_abnormal_salivary_gland | 1.03483331 |
| 84 | MP0010234_abnormal_vibrissa_follicle | 1.01892922 |
| 85 | MP0000427_abnormal_hair_cycle | 0.99045575 |
| 86 | MP0001944_abnormal_pancreas_morphology | 0.97687545 |
| 87 | MP0003045_fibrosis | 0.96465228 |
| 88 | MP0000465_gastrointestinal_hemorrhage | 0.96150701 |
| 89 | MP0008874_decreased_physiological_sensi | 0.95860154 |
| 90 | MP0000371_diluted_coat_color | 0.93754500 |
| 91 | MP0003828_pulmonary_edema | 0.93665508 |
| 92 | MP0004885_abnormal_endolymph | 0.92896639 |
| 93 | MP0004883_abnormal_blood_vessel | 0.92237455 |
| 94 | MP0001756_abnormal_urination | 0.90080075 |
| 95 | MP0005503_abnormal_tendon_morphology | 0.88020312 |
| 96 | MP0002152_abnormal_brain_morphology | 0.87418605 |
| 97 | MP0002006_tumorigenesis | 0.86969304 |
| 98 | MP0008004_abnormal_stomach_pH | 0.86823630 |
| 99 | MP0004484_altered_response_of | 0.85247356 |
| 100 | MP0006276_abnormal_autonomic_nervous | 0.85062574 |
| 101 | MP0000538_abnormal_urinary_bladder | 0.84746552 |
| 102 | MP0002168_other_aberrant_phenotype | 0.84679061 |
| 103 | MP0005645_abnormal_hypothalamus_physiol | 0.84415362 |
| 104 | MP0005171_absent_coat_pigmentation | 0.83147252 |
| 105 | MP0003868_abnormal_feces_composition | 0.81523651 |
| 106 | MP0000003_abnormal_adipose_tissue | 0.80111369 |
| 107 | MP0006072_abnormal_retinal_apoptosis | 0.79669262 |
| 108 | MP0002078_abnormal_glucose_homeostasis | 0.79260292 |
| 109 | MP0003690_abnormal_glial_cell | 0.78267013 |
| 110 | MP0002877_abnormal_melanocyte_morpholog | 0.78170921 |
| 111 | MP0003634_abnormal_glial_cell | 0.78100655 |
| 112 | MP0002971_abnormal_brown_adipose | 0.77102148 |
| 113 | MP0004036_abnormal_muscle_relaxation | 0.76598061 |
| 114 | MP0005167_abnormal_blood-brain_barrier | 0.76215658 |
| 115 | MP0005535_abnormal_body_temperature | 0.75083047 |
| 116 | MP0000383_abnormal_hair_follicle | 0.74078904 |
| 117 | MP0002069_abnormal_eating/drinking_beha | 0.73139958 |
| 118 | MP0003279_aneurysm | 0.72533844 |
| 119 | MP0004742_abnormal_vestibular_system | 0.71770479 |
| 120 | MP0002638_abnormal_pupillary_reflex | 0.71289581 |
| 121 | MP0005164_abnormal_response_to | 0.71161704 |
| 122 | MP0003632_abnormal_nervous_system | 0.70685574 |
| 123 | MP0005253_abnormal_eye_physiology | 0.69452740 |
| 124 | MP0001851_eye_inflammation | 0.68814094 |
| 125 | MP0001661_extended_life_span | 0.67266142 |
| 126 | MP0005379_endocrine/exocrine_gland_phen | 0.66478371 |
| 127 | MP0005464_abnormal_platelet_physiology | 0.65521294 |
| 128 | MP0004145_abnormal_muscle_electrophysio | 0.64977893 |
| 129 | MP0004085_abnormal_heartbeat | 0.61752176 |
| 130 | MP0002837_dystrophic_cardiac_calcinosis | 0.60931537 |
| 131 | MP0001664_abnormal_digestion | 0.60548997 |
| 132 | MP0000920_abnormal_myelination | 0.54360847 |
| 133 | MP0004233_abnormal_muscle_weight | 0.54208618 |
| 134 | MP0004130_abnormal_muscle_cell | 0.53132319 |
| 135 | MP0010307_abnormal_tumor_latency | 0.52850882 |
| 136 | MP0005166_decreased_susceptibility_to | 0.52550269 |
| 137 | MP0002928_abnormal_bile_duct | 0.52243510 |
| 138 | MP0001963_abnormal_hearing_physiology | 0.52157828 |
| 139 | MP0005195_abnormal_posterior_eye | 0.51842696 |
| 140 | MP0008872_abnormal_physiological_respon | 0.51681766 |
| 141 | MP0002095_abnormal_skin_pigmentation | 0.50140505 |
| 142 | MP0002752_abnormal_somatic_nervous | 0.49955686 |
| 143 | MP0001905_abnormal_dopamine_level | 0.49028996 |
| 144 | MP0001765_abnormal_ion_homeostasis | 0.48661577 |
| 145 | MP0005187_abnormal_penis_morphology | 0.48649641 |
| 146 | MP0002693_abnormal_pancreas_physiology | 0.48485443 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.14430240 |
| 2 | Focal seizures (HP:0007359) | 4.81747605 |
| 3 | Visual hallucinations (HP:0002367) | 4.53249870 |
| 4 | Epileptic encephalopathy (HP:0200134) | 3.96484705 |
| 5 | Febrile seizures (HP:0002373) | 3.95944396 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 3.88840263 |
| 7 | Myokymia (HP:0002411) | 3.77764130 |
| 8 | Absence seizures (HP:0002121) | 3.64131824 |
| 9 | Papilledema (HP:0001085) | 3.61024357 |
| 10 | Atonic seizures (HP:0010819) | 3.60206739 |
| 11 | Genetic anticipation (HP:0003743) | 3.38637722 |
| 12 | Supranuclear gaze palsy (HP:0000605) | 3.34223297 |
| 13 | Dialeptic seizures (HP:0011146) | 3.29959118 |
| 14 | Papillary thyroid carcinoma (HP:0002895) | 3.17500053 |
| 15 | Action tremor (HP:0002345) | 3.16650610 |
| 16 | Generalized tonic-clonic seizures (HP:0002069) | 3.07012190 |
| 17 | Gaze-evoked nystagmus (HP:0000640) | 3.05526169 |
| 18 | Truncal ataxia (HP:0002078) | 3.02635902 |
| 19 | Drooling (HP:0002307) | 3.02211356 |
| 20 | Excessive salivation (HP:0003781) | 3.02211356 |
| 21 | Impaired smooth pursuit (HP:0007772) | 3.01751083 |
| 22 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.00672370 |
| 23 | Hematochezia (HP:0002573) | 2.98532604 |
| 24 | Acute myeloid leukemia (HP:0004808) | 2.90491600 |
| 25 | Broad-based gait (HP:0002136) | 2.85286607 |
| 26 | Inappropriate behavior (HP:0000719) | 2.84946038 |
| 27 | Postural instability (HP:0002172) | 2.81685808 |
| 28 | Menstrual irregularities (HP:0000858) | 2.78378442 |
| 29 | Dysmetric saccades (HP:0000641) | 2.78141807 |
| 30 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.76086664 |
| 31 | Thyroid carcinoma (HP:0002890) | 2.73122692 |
| 32 | Mutism (HP:0002300) | 2.73065107 |
| 33 | Diplopia (HP:0000651) | 2.71909019 |
| 34 | Abnormality of binocular vision (HP:0011514) | 2.71909019 |
| 35 | Relative macrocephaly (HP:0004482) | 2.69932254 |
| 36 | Testicular neoplasm (HP:0010788) | 2.69220758 |
| 37 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.67951627 |
| 38 | Dysdiadochokinesis (HP:0002075) | 2.63924556 |
| 39 | Absent frontal sinuses (HP:0002688) | 2.62051726 |
| 40 | Dysmetria (HP:0001310) | 2.60605580 |
| 41 | Absent speech (HP:0001344) | 2.60588292 |
| 42 | Macroorchidism (HP:0000053) | 2.56855599 |
| 43 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.54988721 |
| 44 | Depression (HP:0000716) | 2.54076598 |
| 45 | Overgrowth (HP:0001548) | 2.53919313 |
| 46 | Prolonged bleeding time (HP:0003010) | 2.53863671 |
| 47 | Widely spaced teeth (HP:0000687) | 2.49376993 |
| 48 | Mitral stenosis (HP:0001718) | 2.48878653 |
| 49 | Ventricular fibrillation (HP:0001663) | 2.47635564 |
| 50 | Abnormal social behavior (HP:0012433) | 2.47588068 |
| 51 | Impaired social interactions (HP:0000735) | 2.47588068 |
| 52 | Central scotoma (HP:0000603) | 2.46694488 |
| 53 | Poor eye contact (HP:0000817) | 2.45078825 |
| 54 | Episodic fever (HP:0001954) | 2.41138455 |
| 55 | Congenital stationary night blindness (HP:0007642) | 2.40592210 |
| 56 | Hamartoma of the eye (HP:0010568) | 2.39454701 |
| 57 | Pheochromocytoma (HP:0002666) | 2.37861934 |
| 58 | Neuronal loss in central nervous system (HP:0002529) | 2.36662369 |
| 59 | Protruding tongue (HP:0010808) | 2.36477873 |
| 60 | Abnormality of macular pigmentation (HP:0008002) | 2.35211888 |
| 61 | Hyperventilation (HP:0002883) | 2.32673223 |
| 62 | Stereotypic behavior (HP:0000733) | 2.32082793 |
| 63 | Cerebral inclusion bodies (HP:0100314) | 2.30789535 |
| 64 | Hemiplegia (HP:0002301) | 2.30263822 |
| 65 | Hyperthyroidism (HP:0000836) | 2.28010127 |
| 66 | Increased cerebral lipofuscin (HP:0011813) | 2.27602574 |
| 67 | Enlarged penis (HP:0000040) | 2.25421223 |
| 68 | Scanning speech (HP:0002168) | 2.21401664 |
| 69 | Global brain atrophy (HP:0002283) | 2.20227029 |
| 70 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.18388065 |
| 71 | Curly hair (HP:0002212) | 2.16813883 |
| 72 | Orthostatic hypotension (HP:0001278) | 2.16413827 |
| 73 | Gingival bleeding (HP:0000225) | 2.14883915 |
| 74 | Aortic aneurysm (HP:0004942) | 2.12313030 |
| 75 | Amblyopia (HP:0000646) | 2.12216394 |
| 76 | Short chin (HP:0000331) | 2.11283314 |
| 77 | Conjunctival hamartoma (HP:0100780) | 2.09318240 |
| 78 | Progressive inability to walk (HP:0002505) | 2.06503971 |
| 79 | Urinary urgency (HP:0000012) | 2.06421535 |
| 80 | Epileptiform EEG discharges (HP:0011182) | 2.05335296 |
| 81 | Spontaneous hematomas (HP:0007420) | 2.04991441 |
| 82 | Volvulus (HP:0002580) | 2.03428038 |
| 83 | Neurofibrillary tangles (HP:0002185) | 2.03325044 |
| 84 | Bradykinesia (HP:0002067) | 2.02055756 |
| 85 | Anxiety (HP:0000739) | 2.00939319 |
| 86 | Apathy (HP:0000741) | 2.00846585 |
| 87 | Abnormality of salivation (HP:0100755) | 2.00711114 |
| 88 | Abnormal eating behavior (HP:0100738) | 2.00119879 |
| 89 | Insidious onset (HP:0003587) | 1.98981087 |
| 90 | Termporal pattern (HP:0011008) | 1.98981087 |
| 91 | Hypothermia (HP:0002045) | 1.98845997 |
| 92 | Hypoglycemic seizures (HP:0002173) | 1.98788512 |
| 93 | Agitation (HP:0000713) | 1.98646309 |
| 94 | Asymmetry of the thorax (HP:0001555) | 1.96238527 |
| 95 | Ankle clonus (HP:0011448) | 1.95720125 |
| 96 | Lower limb amyotrophy (HP:0007210) | 1.94362450 |
| 97 | Polycythemia (HP:0001901) | 1.94066970 |
| 98 | Hemiparesis (HP:0001269) | 1.93422234 |
| 99 | Resting tremor (HP:0002322) | 1.93155163 |
| 100 | Blue irides (HP:0000635) | 1.92232612 |
| 101 | Fair hair (HP:0002286) | 1.90923467 |
| 102 | Pointed chin (HP:0000307) | 1.90511565 |
| 103 | Generalized hypopigmentation of hair (HP:0011358) | 1.89563084 |
| 104 | Increased CSF protein (HP:0002922) | 1.89302262 |
| 105 | EEG with generalized epileptiform discharges (HP:0011198) | 1.88888330 |
| 106 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.88226943 |
| 107 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.88226943 |
| 108 | Hypoglycemic coma (HP:0001325) | 1.87551387 |
| 109 | Subacute progressive viral hepatitis (HP:0006572) | 1.86552178 |
| 110 | Disinhibition (HP:0000734) | 1.86342676 |
| 111 | Intention tremor (HP:0002080) | 1.86172352 |
| 112 | Open mouth (HP:0000194) | 1.84662579 |
| 113 | Impaired vibratory sensation (HP:0002495) | 1.84359337 |
| 114 | Abnormality of the corticospinal tract (HP:0002492) | 1.84348040 |
| 115 | Spastic gait (HP:0002064) | 1.83975271 |
| 116 | Psychosis (HP:0000709) | 1.82796030 |
| 117 | Ocular albinism (HP:0001107) | 1.81809211 |
| 118 | Peritonitis (HP:0002586) | 1.81543534 |
| 119 | Diminished motivation (HP:0000745) | 1.79591171 |
| 120 | Aqueductal stenosis (HP:0002410) | 1.78552131 |
| 121 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.77265376 |
| 122 | Truncal obesity (HP:0001956) | 1.77261881 |
| 123 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.76232380 |
| 124 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.75934694 |
| 125 | Neuroendocrine neoplasm (HP:0100634) | 1.73475796 |
| 126 | Acanthocytosis (HP:0001927) | 1.73422406 |
| 127 | Abnormality of the fingertips (HP:0001211) | 1.73025716 |
| 128 | Rapidly progressive (HP:0003678) | 1.72132683 |
| 129 | Hyperglycemia (HP:0003074) | 1.70978024 |
| 130 | Bradycardia (HP:0001662) | 1.70278211 |
| 131 | Iris hypopigmentation (HP:0007730) | 1.70228069 |
| 132 | Urethral obstruction (HP:0000796) | 1.69648470 |
| 133 | Narrow palate (HP:0000189) | 1.69525783 |
| 134 | Hypsarrhythmia (HP:0002521) | 1.68595544 |
| 135 | Ankyloglossia (HP:0010296) | 1.68595037 |
| 136 | Striae distensae (HP:0001065) | 1.68216174 |
| 137 | Lower limb asymmetry (HP:0100559) | 1.67265992 |
| 138 | Generalized myoclonic seizures (HP:0002123) | 1.66332720 |
| 139 | Slow saccadic eye movements (HP:0000514) | 1.66326996 |
| 140 | Lower limb muscle weakness (HP:0007340) | 1.66216345 |
| 141 | Status epilepticus (HP:0002133) | 1.66096344 |
| 142 | Difficulty running (HP:0009046) | 1.65592992 |
| 143 | Abnormality of saccadic eye movements (HP:0000570) | 1.65572073 |
| 144 | Obsessive-compulsive behavior (HP:0000722) | 1.65167698 |
| 145 | Submucous cleft hard palate (HP:0000176) | 1.64529357 |
| 146 | Fetal akinesia sequence (HP:0001989) | 1.64083762 |
| 147 | Dilatation of the ascending aorta (HP:0005111) | 1.64038629 |
| 148 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.63712431 |
| 149 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.63253028 |
| 150 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.63253028 |
| 151 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.63253028 |
| 152 | Thickened calvaria (HP:0002684) | 1.63062460 |
| 153 | Sandal gap (HP:0001852) | 1.62026085 |
| 154 | Tapered finger (HP:0001182) | 1.61860937 |
| 155 | Poikilocytosis (HP:0004447) | 1.60993141 |
| 156 | Craniofacial hyperostosis (HP:0004493) | 1.60144356 |
| 157 | Clonus (HP:0002169) | 1.59897362 |
| 158 | Cranial hyperostosis (HP:0004437) | 1.57590615 |
| 159 | Metaphyseal dysplasia (HP:0100255) | 1.57046172 |
| 160 | Cubitus valgus (HP:0002967) | 1.56679227 |
| 161 | Neoplasm of the thyroid gland (HP:0100031) | 1.56408314 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.40267450 |
| 2 | RIPK4 | 4.01481151 |
| 3 | EPHA4 | 3.56545855 |
| 4 | MAP3K9 | 3.44642506 |
| 5 | MAP3K4 | 2.92938281 |
| 6 | AKT3 | 2.54610345 |
| 7 | ACVR1B | 2.45562198 |
| 8 | KSR2 | 2.31194136 |
| 9 | TRPM7 | 2.25832177 |
| 10 | MAP2K7 | 2.25695266 |
| 11 | DAPK2 | 2.21073974 |
| 12 | FES | 2.12412685 |
| 13 | MAP3K13 | 2.07986431 |
| 14 | MINK1 | 2.05075779 |
| 15 | PAK6 | 2.04033924 |
| 16 | MAP2K4 | 1.98770901 |
| 17 | SIK2 | 1.97696130 |
| 18 | CAMK1G | 1.79490257 |
| 19 | MAP3K6 | 1.72159676 |
| 20 | CAMKK1 | 1.71403001 |
| 21 | MAP3K12 | 1.64319357 |
| 22 | PRKD3 | 1.53643901 |
| 23 | PIK3CG | 1.51847008 |
| 24 | TAOK3 | 1.51593711 |
| 25 | STK38 | 1.50449482 |
| 26 | NTRK2 | 1.49392791 |
| 27 | DAPK1 | 1.49316541 |
| 28 | FGFR2 | 1.45685134 |
| 29 | NTRK1 | 1.40521925 |
| 30 | KSR1 | 1.40151955 |
| 31 | MAP3K2 | 1.37392398 |
| 32 | TAOK1 | 1.35372672 |
| 33 | PLK2 | 1.35122489 |
| 34 | MARK1 | 1.32688314 |
| 35 | BMPR1B | 1.31496311 |
| 36 | RET | 1.29222631 |
| 37 | CDK5 | 1.28257846 |
| 38 | CAMKK2 | 1.28121370 |
| 39 | SGK2 | 1.21542426 |
| 40 | SGK3 | 1.20797549 |
| 41 | RAF1 | 1.19917546 |
| 42 | IRAK1 | 1.13636897 |
| 43 | IRAK2 | 1.12493731 |
| 44 | TEC | 1.12032681 |
| 45 | BMPR2 | 1.11948528 |
| 46 | NLK | 1.11830143 |
| 47 | CAMK1D | 1.09070967 |
| 48 | PNCK | 1.08996655 |
| 49 | PRKCH | 1.07508917 |
| 50 | MAP2K3 | 1.05460926 |
| 51 | YES1 | 1.04716266 |
| 52 | SCYL2 | 1.03237758 |
| 53 | MAP3K1 | 1.00230564 |
| 54 | PRKG2 | 0.99082991 |
| 55 | PINK1 | 0.98977706 |
| 56 | SGK1 | 0.95315939 |
| 57 | DMPK | 0.95103416 |
| 58 | PTK2B | 0.90275761 |
| 59 | PDK1 | 0.89846318 |
| 60 | EPHA3 | 0.89051672 |
| 61 | ERBB3 | 0.89038795 |
| 62 | RIPK1 | 0.86913062 |
| 63 | TYK2 | 0.86644601 |
| 64 | SGK494 | 0.84246115 |
| 65 | SGK223 | 0.84246115 |
| 66 | GRK5 | 0.84122900 |
| 67 | STK11 | 0.82306597 |
| 68 | TNIK | 0.81355269 |
| 69 | FRK | 0.79801643 |
| 70 | MAP3K7 | 0.79530116 |
| 71 | CAMK1 | 0.78043150 |
| 72 | MAPK13 | 0.78028565 |
| 73 | TNK2 | 0.76854129 |
| 74 | PDPK1 | 0.76509763 |
| 75 | PKN2 | 0.72857376 |
| 76 | HIPK2 | 0.72137003 |
| 77 | CCNB1 | 0.70870621 |
| 78 | PRKCG | 0.70237139 |
| 79 | ALK | 0.67970803 |
| 80 | MAPK10 | 0.67747191 |
| 81 | MARK2 | 0.67733434 |
| 82 | FGR | 0.67201133 |
| 83 | CAMK2A | 0.67168689 |
| 84 | PRPF4B | 0.65679680 |
| 85 | MAP2K1 | 0.63332183 |
| 86 | CSNK1G2 | 0.63258356 |
| 87 | MAP3K14 | 0.63225402 |
| 88 | PDGFRA | 0.60986157 |
| 89 | RPS6KB1 | 0.60762311 |
| 90 | STK3 | 0.60214324 |
| 91 | INSRR | 0.59400837 |
| 92 | HCK | 0.58861007 |
| 93 | RPS6KA2 | 0.58836553 |
| 94 | BTK | 0.58108067 |
| 95 | PHKG1 | 0.57616590 |
| 96 | PHKG2 | 0.57616590 |
| 97 | LATS2 | 0.55932054 |
| 98 | JAK1 | 0.55416879 |
| 99 | SYK | 0.54834266 |
| 100 | CDK19 | 0.54333177 |
| 101 | FYN | 0.53849739 |
| 102 | CASK | 0.51596213 |
| 103 | DYRK1A | 0.51584982 |
| 104 | PRKAA2 | 0.51135521 |
| 105 | TYRO3 | 0.49752632 |
| 106 | WNK1 | 0.49719210 |
| 107 | RPS6KA3 | 0.49032511 |
| 108 | PRKCE | 0.48675809 |
| 109 | BLK | 0.47856730 |
| 110 | MAP2K6 | 0.47403238 |
| 111 | MAP3K5 | 0.46560676 |
| 112 | ZAP70 | 0.45742505 |
| 113 | BRSK2 | 0.44199335 |
| 114 | ARAF | 0.43775407 |
| 115 | PDGFRB | 0.43008262 |
| 116 | FLT3 | 0.42561657 |
| 117 | CDK12 | 0.41281466 |
| 118 | UHMK1 | 0.40910779 |
| 119 | JAK2 | 0.40517296 |
| 120 | FGFR3 | 0.40410150 |
| 121 | PTK2 | 0.40409861 |
| 122 | KIT | 0.40201745 |
| 123 | EEF2K | 0.39442546 |
| 124 | CAMK2B | 0.37966358 |
| 125 | CAMK4 | 0.37362457 |
| 126 | GRK6 | 0.37045368 |
| 127 | PAK3 | 0.36648184 |
| 128 | PRKAA1 | 0.35520195 |
| 129 | CDC42BPA | 0.35494240 |
| 130 | PRKCB | 0.34960718 |
| 131 | CDK18 | 0.34337228 |
| 132 | CDK15 | 0.33641461 |
| 133 | PRKCQ | 0.33471073 |
| 134 | JAK3 | 0.33428760 |
| 135 | MAPK12 | 0.31416068 |
| 136 | FER | 0.29872553 |
| 137 | CDK14 | 0.29688876 |
| 138 | BRD4 | 0.28935659 |
| 139 | PRKD2 | 0.28503014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.85673611 |
| 2 | Long-term potentiation_Homo sapiens_hsa04720 | 2.46601271 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.35362925 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.24531087 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.16829023 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.16734719 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.10354827 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.05038818 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.02324002 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 1.98499182 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 1.93826270 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.81885837 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.77238208 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.74685098 |
| 15 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.70895924 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.67157414 |
| 17 | Phototransduction_Homo sapiens_hsa04744 | 1.66753436 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.61981105 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.56199351 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.52094758 |
| 21 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.49079112 |
| 22 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.48702730 |
| 23 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.47973659 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.47766365 |
| 25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.47738840 |
| 26 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.47476113 |
| 27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.35728761 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.34637081 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.34544237 |
| 30 | Taste transduction_Homo sapiens_hsa04742 | 1.34542442 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.33023242 |
| 32 | Glioma_Homo sapiens_hsa05214 | 1.31982852 |
| 33 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.27035277 |
| 34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26830556 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26249978 |
| 36 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.20208229 |
| 37 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.18696521 |
| 38 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.14658558 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12611847 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.11588748 |
| 41 | Gap junction_Homo sapiens_hsa04540 | 1.08538680 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.07849046 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03550152 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01102405 |
| 45 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.00665880 |
| 46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.00345576 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.99697850 |
| 48 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.98695571 |
| 49 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.98461162 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98158413 |
| 51 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.97643828 |
| 52 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.96573749 |
| 53 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.96545498 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.95792586 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.91895180 |
| 56 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.90687050 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86782459 |
| 58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86398586 |
| 59 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.85882589 |
| 60 | Insulin resistance_Homo sapiens_hsa04931 | 0.85545297 |
| 61 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.85104245 |
| 62 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84435404 |
| 63 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.83379058 |
| 64 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.83365340 |
| 65 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82462080 |
| 66 | Melanogenesis_Homo sapiens_hsa04916 | 0.79815197 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 0.79743087 |
| 68 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79641668 |
| 69 | Focal adhesion_Homo sapiens_hsa04510 | 0.78446873 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75278680 |
| 71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75144489 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74368423 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.73787646 |
| 74 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71591604 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71297186 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.70741789 |
| 77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.69205101 |
| 78 | Mineral absorption_Homo sapiens_hsa04978 | 0.69198560 |
| 79 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.65078893 |
| 80 | Axon guidance_Homo sapiens_hsa04360 | 0.64337399 |
| 81 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64319765 |
| 82 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.64276612 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63669153 |
| 84 | Prostate cancer_Homo sapiens_hsa05215 | 0.63634865 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63326057 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62812383 |
| 87 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62361492 |
| 88 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61951130 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61732970 |
| 90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61519291 |
| 91 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61439205 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61352950 |
| 93 | Tuberculosis_Homo sapiens_hsa05152 | 0.60234826 |
| 94 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59786868 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58915678 |
| 96 | Melanoma_Homo sapiens_hsa05218 | 0.58123750 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58008638 |
| 98 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57867782 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56873446 |
| 100 | ABC transporters_Homo sapiens_hsa02010 | 0.56447977 |
| 101 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.56032163 |
| 102 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55734188 |
| 103 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54876342 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.54849554 |
| 105 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.54571686 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52904954 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.51669095 |
| 108 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.51057014 |
| 109 | Lysosome_Homo sapiens_hsa04142 | 0.50799016 |
| 110 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.49885100 |
| 111 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.49850044 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49433733 |
| 113 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49339244 |
| 114 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48744385 |
| 115 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45697751 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45144974 |
| 117 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43578818 |
| 118 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42189408 |
| 119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41813598 |
| 120 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.39216203 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38976571 |

